These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17458212)

  • 1. [Pathogenesis and etiology of cardiovascular disease: role of insulin resistance].
    Takahashi A; Kushiro T
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():163-8. PubMed ID: 17458212
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of insulin resistance in hypertensive rats.
    Shimamoto K; Ura N
    Clin Exp Hypertens; 2006 Aug; 28(6):543-52. PubMed ID: 16893759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones.
    Nesto R
    Diabet Med; 2004 Aug; 21(8):810-7. PubMed ID: 15270782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance: the clinical spectrum.
    Mantzoros CS; Flier JS
    Adv Endocrinol Metab; 1995; 6():193-232. PubMed ID: 7671097
    [No Abstract]   [Full Text] [Related]  

  • 5. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance and cardiovascular disease.
    Ginsberg HN
    J Clin Invest; 2000 Aug; 106(4):453-8. PubMed ID: 10953019
    [No Abstract]   [Full Text] [Related]  

  • 7. Spotlight on renin. The renin system, salt-sensitivity and metabolic syndrome.
    Fujita T
    J Renin Angiotensin Aldosterone Syst; 2006 Sep; 7(3):181-3. PubMed ID: 17094057
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical diagnosis of metabolic and cardiovascular risks in overweight children: early development of chronic diseases in the obese child.
    l'Allemand-Jander D
    Int J Obes (Lond); 2010 Dec; 34 Suppl 2():S32-6. PubMed ID: 21151144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemic obesity and the metabolic syndrome.
    Haffner S; Taegtmeyer H
    Circulation; 2003 Sep; 108(13):1541-5. PubMed ID: 14517149
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
    Chapman MJ; Sposito AC
    Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Involvement of PPARgamma in the pathogenesis of hypertension and hypertensive target-organ damage].
    Itoh H
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():179-90. PubMed ID: 15171366
    [No Abstract]   [Full Text] [Related]  

  • 12. Obesity-related cardiovascular disease: implications of obstructive sleep apnea.
    Wolk R; Somers VK
    Diabetes Obes Metab; 2006 May; 8(3):250-60. PubMed ID: 16634984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multiphasic action of AT1 receptor blockers and their therapeutic effects for cardiovascular diseases].
    Mitsuyama K
    Nihon Yakurigaku Zasshi; 2008 Mar; 131(3):176-7. PubMed ID: 18350678
    [No Abstract]   [Full Text] [Related]  

  • 14. [Obesity and insulin resistance syndrome].
    Tokunaga K; Matsuzawa Y
    Nihon Rinsho; 1996 Oct; 54(10):2679-86. PubMed ID: 8914427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance syndrome: a potent culprit in cardiovascular disease.
    Coulston AM; Peragallo-Dittko V
    J Am Diet Assoc; 2004 Feb; 104(2):176-9. PubMed ID: 14760563
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of abnormalities of carbohydrate and lipoprotein metabolism in the pathogenesis and clinical course of hypertension.
    Reaven GM
    J Cardiovasc Pharmacol; 1990; 15 Suppl 5():S4-7. PubMed ID: 1694930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic criteria of insulin resistance and multiple risk factor syndrome].
    Hashimoto N; Saito Y
    Nihon Rinsho; 2000 Feb; 58(2):405-10. PubMed ID: 10707566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical implications of insulin resistance.
    Peters AL
    Am J Manag Care; 2000 Aug; 6(13 Suppl):S668-74; discussion S675-81. PubMed ID: 11183420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance and the metabolic syndrome as predictors of cardiovascular risk: where are we now?
    Sattar N
    Minerva Endocrinol; 2005 Sep; 30(3):121-38. PubMed ID: 16208304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk of cardiovascular diseases in relation to insulin resistance: the Tanno-Sobetsu study].
    Saitoh S
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():59-63. PubMed ID: 17458195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.